The Valley Desk

Clinical trial reportThe New England journal of medicinePublished

CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat β-Thalassemia

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Children’s Hospital of Philadelphia. Affiliation source

Publication record

Type
Clinical trial report
Venue
The New England journal of medicine
Published
Subject terms
Neutrophils; Humans; beta-Thalassemia; Busulfan; Fetal Hemoglobin; Repressor Proteins; Myeloablative Agonists; Treatment Outcome; Erythrocyte Transfusion; Transplantation Conditioning; Hematopoietic Stem Cell Transplantation; Adolescent
PubMed ID
41931048
Added to directory
Source checked

Report a correction or request removal